{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T09:55:49Z","timestamp":1720778149637},"reference-count":56,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.9535","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T06:36:46Z","timestamp":1538980606000},"source":"Crossref","is-referenced-by-count":1,"title":["Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea"],"prefix":"10.3892","author":[{"given":"Ana","family":"Azevedo","sequence":"first","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (Toxomics), Genetics, Oncology and Human Toxicology, NOVA Medical School\/Faculty of Medical Sciences, Universidade Nova de Lisboa, 1150\u2011082 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Silva","sequence":"additional","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (Toxomics), Genetics, Oncology and Human Toxicology, NOVA Medical School\/Faculty of Medical Sciences, Universidade Nova de Lisboa, 1150\u2011082 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Reichert","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Hospital of S\ufffdo Francisco Xavier, West Lisbon Hospital Centre, 1449\u2011005 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Lima","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology, Hospital of S\ufffdo Francisco Xavier, West Lisbon Hospital Centre, 1449\u2011005 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmeraldina","family":"J\ufffdnior","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Hospital of S\ufffdo Francisco Xavier, West Lisbon Hospital Centre, 1449\u2011005 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\ufffd","family":"Rueff","sequence":"additional","affiliation":[{"name":"Centre for Toxicogenomics and Human Health (Toxomics), Genetics, Oncology and Human Toxicology, NOVA Medical School\/Faculty of Medical Sciences, Universidade Nova de Lisboa, 1150\u2011082 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"key20200713231216_b1-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12885-016-2208-2","article-title":"Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey","volume":"16","author":"Mesa","year":"2016","journal-title":"BMC Cancer"},{"key":"key20200713231216_b2-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.beha.2014.07.003","article-title":"Leukemic transformation in myeloproliferative neoplasms: Therapy-related or unrelated?","volume":"27","author":"Bj\u00f6rkholm","year":"2014","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20200713231216_b3-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1182\/blood-2012-02-411215","article-title":"A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera","volume":"119","author":"Hern\u00e1ndez-Boluda","year":"2012","journal-title":"Blood"},{"key":"key20200713231216_b4-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am J Med"},{"key":"key20200713231216_b5-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4065\/81.2.159","article-title":"Essential thrombocythemia beyond the first decade: Life expectancy, long-term complication rates, and prognostic factors","volume":"81","author":"Wolanskyj","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"key20200713231216_b6-mmr-18-06-5243","volume-title":"WHO Classification of Tumours of Haematopioetic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"Fourth edition"},{"key":"key20200713231216_b7-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"E5401","DOI":"10.1073\/pnas.1407792111","article-title":"Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms","volume":"111","author":"Rampal","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713231216_b8-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12185-010-0530-z","article-title":"Molecular aspects of myeloproliferative neoplasms","volume":"91","author":"Delhommeau","year":"2010","journal-title":"Int J Hematol"},{"key":"key20200713231216_b9-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.leukres.2006.01.016","article-title":"Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression","volume":"30","author":"Bolufer","year":"2006","journal-title":"Leuk Res"},{"key":"key20200713231216_b10-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2009-08-236596","article-title":"Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm","volume":"115","author":"Beer","year":"2010","journal-title":"Blood"},{"key":"key20200713231216_b11-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"e112786","DOI":"10.1371\/journal.pone.0112786","article-title":"Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression","volume":"9","author":"Hasselbalch","year":"2014","journal-title":"PLoS One"},{"key":"key20200713231216_b12-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/leu.2008.229","article-title":"JAK2 and MPL mutations in myeloproliferative neoplasms: Discovery and science","volume":"22","author":"Kilpivaara","year":"2008","journal-title":"Leukemia"},{"key":"key20200713231216_b13-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/cam4.1081","article-title":"Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia","volume":"6","author":"Santoro","year":"2017","journal-title":"Cancer Med"},{"key":"key20200713231216_b14-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4274\/tjh.2015.0041","article-title":"Clinical features of 294 turkish patients with chronic myeloproliferative neoplasms","volume":"33","author":"And\u0131\u00e7","year":"2016","journal-title":"Turk J Haematol"},{"key":"key20200713231216_b15-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00277-015-2357-4","article-title":"Current and future treatment options for polycythemia vera","volume":"94","author":"Griesshammer","year":"2015","journal-title":"Ann Hematol"},{"key":"key20200713231216_b16-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.3892\/ol.2017.6065","article-title":"DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms","volume":"13","author":"Azevedo","year":"2017","journal-title":"Oncol Lett"},{"key":"key20200713231216_b17-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative neoplasms: A contemporary review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol"},{"key":"key20200713231216_b18-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5581\/1516-8484.20120035","article-title":"Molecular biology of Philadelphia-negative myeloproliferative neoplasms","volume":"34","author":"Campregher","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"key":"key20200713231216_b19-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1590\/S1679-45082013000400025","article-title":"Apoptosis deregulation in myeloproliferative neoplasms","volume":"11","author":"Tognon","year":"2013","journal-title":"Einstein (Sao Paulo)"},{"key":"key20200713231216_b20-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.celrep.2014.06.046","article-title":"Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects","volume":"8","author":"Wang","year":"2014","journal-title":"Cell Rep"},{"key":"key20200713231216_b21-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"213790","DOI":"10.1155\/2014\/213790","article-title":"Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia","volume":"2014","author":"B\u0103nescu","year":"2014","journal-title":"Biomed Res Int"},{"key":"key20200713231216_b22-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N Engl J Med"},{"key":"key20200713231216_b23-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.beha.2009.08.006","article-title":"Mechanisms of mutations in myeloproliferative neoplasms","volume":"22","author":"Levine","year":"2009","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20200713231216_b24-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.leukres.2008.11.005","article-title":"DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia","volume":"33","author":"Batar","year":"2009","journal-title":"Leuk Res"},{"key":"key20200713231216_b25-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/10409230802309905","article-title":"Base excision repair and its role in maintaining genome stability","volume":"43","author":"Baute","year":"2008","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"key20200713231216_b26-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","article-title":"Genome maintenance mechanisms for preventing cancer","volume":"411","author":"Hoeijmakers","year":"2001","journal-title":"Nature"},{"key":"key20200713231216_b27-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1179\/1607845412Y.0000000040","article-title":"Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India","volume":"18","author":"Annamaneni","year":"2013","journal-title":"Hematology"},{"key":"key20200713231216_b28-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3109\/10428194.2013.855307","article-title":"Targeting the apoptosis pathway in hematologic malignancies","volume":"55","author":"Zaman","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"key20200713231216_b29-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/sj.leu.2403383","article-title":"Apoptotic mechanisms in the control of erythropoiesis","volume":"18","author":"Testa","year":"2004","journal-title":"Leukemia"},{"key":"key20200713231216_b30-mmr-18-06-5243","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2016-203625","article-title":"Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms","author":"Malherbe","year":"2016","journal-title":"J Clin Pathol"},{"key":"key20200713231216_b31-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3109\/10428194.2013.767453","article-title":"Differential expression of apoptomiRs in myeloproliferative neoplasms","volume":"54","author":"Nunes","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"key20200713231216_b32-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1756-8722-5-2","article-title":"Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis","volume":"5","author":"Tognon","year":"2012","journal-title":"J Hematol Oncol"},{"key":"key20200713231216_b33-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3109\/10428194.2015.1071491","article-title":"Apoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms","volume":"57","author":"Tognon","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"key20200713231216_b34-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/jcp.2010.080895","article-title":"Differential expression of apoptosis-related genes from death receptor pathway in chronic myeloproliferative diseases","volume":"64","author":"Tognon","year":"2011","journal-title":"J Clin Pathol"},{"key":"key20200713231216_b35-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/cdd.2011.30","article-title":"Caspases and cancer","volume":"18","author":"Olsson","year":"2011","journal-title":"Cell Death Differ"},{"key":"key20200713231216_b36-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ajh.24221","article-title":"Myeloproliferative neoplasms: A decade of discoveries and treatment advances","volume":"91","author":"Tefferi","year":"2016","journal-title":"Am J Hematol"},{"key":"key20200713231216_b37-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1182\/blood-2016-10-695957","article-title":"Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms","volume":"129","author":"Rumi","year":"2017","journal-title":"Blood"},{"key":"key20200713231216_b38-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1007\/s12032-012-0202-3","article-title":"Impaired apoptosis of megakaryocytes and bone marrow mononuclear cells in essential thrombocythemia: Correlation with JAK2V617F mutational status and cytoreductive therapy","volume":"29","author":"Treli\u0144ski","year":"2012","journal-title":"Med Oncol"},{"key":"key20200713231216_b39-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/sj.leu.2404955","article-title":"Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leukemia"},{"key":"key20200713231216_b40-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key20200713231216_b41-mmr-18-06-5243","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-018-0411-y","article-title":"The role of caspase genes polymorphisms in genetic susceptibility to philadelphia-negative myeloproliferative neoplasms in a Portuguese population","author":"Azevedo","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"key20200713231216_b42-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3892\/br.2017.977","article-title":"Prevalence of the Janus kinase 2 V617F mutation in Philadelphia-negative myeloproliferative neoplasms in a Portuguese population","volume":"7","author":"Azevedo","year":"2017","journal-title":"Biomed Rep"},{"key":"key20200713231216_b43-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/bjh.14061","article-title":"Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic\/myeloproliferative neoplasms in the United States, 2001\u20132001","volume":"174","author":"Srour","year":"2016","journal-title":"Br J Haematol"},{"key":"key20200713231216_b44-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12185-008-0188-y","article-title":"Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: A single center experience from China","volume":"88","author":"Bai","year":"2008","journal-title":"Int J Hematol"},{"key":"key20200713231216_b45-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: A study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica"},{"key":"key20200713231216_b46-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/sj.leu.2404500","article-title":"Risk stratification for survival and leukemic transformation in essential thrombocythemia: A single institutional study of 605 patients","volume":"21","author":"Gangat","year":"2007","journal-title":"Leukemia"},{"key":"key20200713231216_b47-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"key":"key20200713231216_b48-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"key":"key20200713231216_b49-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrm2153","article-title":"The apoptosome: Signalling platform of cell death","volume":"8","author":"Riedl","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200713231216_b50-mmr-18-06-5243","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006080","article-title":"Cell death signaling","volume":"7","author":"Green","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20200713231216_b51-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1007\/s13277-016-5035-9","article-title":"Major apoptotic mechanisms and genes involved in apoptosis","volume":"37","author":"Kiraz","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200713231216_b52-mmr-18-06-5243","first-page":"82","article-title":"Caspases and cancer: Mechanisms of inactivation and new treatment modalities","volume":"26","author":"Philchenkov","year":"2004","journal-title":"Exp Oncol"},{"key":"key20200713231216_b53-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"10301","DOI":"10.1074\/jbc.274.15.10301","article-title":"Molecular cloning and characterization of two novel pro-apoptotic isoforms of caspase-10","volume":"274","author":"Ng","year":"1999","journal-title":"J Biol Chem"},{"key":"key20200713231216_b54-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.drup.2005.05.001","article-title":"The role of caspases in cell death and differentiation","volume":"8","author":"Oliver","year":"2005","journal-title":"Drug Resist Updat"},{"key":"key20200713231216_b55-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","article-title":"Molecular mechanisms of apoptosis and roles in cancer development and treatment","volume":"16","author":"Goldar","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20200713231216_b56-mmr-18-06-5243","doi-asserted-by":"publisher","first-page":"38905","DOI":"10.1074\/jbc.M004714200","article-title":"Essential role for caspase-8 in transcription-independent apoptosis triggered by p53","volume":"275","author":"Ding","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T23:04:48Z","timestamp":1594681488000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.9535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":56,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.9535","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]}}}